Michael Halberthal

2.3k total citations
37 papers, 812 citations indexed

About

Michael Halberthal is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Michael Halberthal has authored 37 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Michael Halberthal's work include SARS-CoV-2 and COVID-19 Research (9 papers), Disaster Response and Management (6 papers) and COVID-19 Clinical Research Studies (5 papers). Michael Halberthal is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), Disaster Response and Management (6 papers) and COVID-19 Clinical Research Studies (5 papers). Michael Halberthal collaborates with scholars based in Israel, Canada and Netherlands. Michael Halberthal's co-authors include Moran Szwarcwort‐Cohen, Gad Bar‐Joseph, Raphael Beck, Tamar Hashimshony, Amir Argoetti, Yuval Geffen, Yael Mandel‐Gutfreund, Idan Yelin, Einat Shaer Tamar and Roy Kishony and has published in prestigious journals such as Clinical Infectious Diseases, Critical Care Medicine and Annals of Oncology.

In The Last Decade

Michael Halberthal

35 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Halberthal Israel 12 394 237 168 125 124 37 812
Guqin Zhang China 13 961 2.4× 158 0.7× 80 0.5× 226 1.8× 118 1.0× 27 1.4k
Zhenshun Cheng China 12 1.2k 3.1× 195 0.8× 80 0.5× 252 2.0× 108 0.9× 30 1.6k
Tanveer Mir United States 14 208 0.5× 101 0.4× 159 0.9× 31 0.2× 39 0.3× 107 656
Andrea Campana Italy 14 308 0.8× 117 0.5× 93 0.6× 56 0.4× 24 0.2× 34 632
Axel Moreira United States 8 451 1.1× 187 0.8× 426 2.5× 61 0.5× 104 0.8× 14 879
Andrea Bottazzi Italy 6 547 1.4× 52 0.2× 119 0.7× 94 0.8× 50 0.4× 14 789
Roshni Mathew United States 9 435 1.1× 122 0.5× 284 1.7× 46 0.4× 73 0.6× 19 728
Ilka Regina Souza de Oliveira Brazil 12 202 0.5× 102 0.4× 177 1.1× 101 0.8× 26 0.2× 34 796
Huaqin Pan China 11 509 1.3× 73 0.3× 57 0.3× 156 1.2× 22 0.2× 30 776
Karuna M. Das India 15 505 1.3× 321 1.4× 281 1.7× 135 1.1× 60 0.5× 56 1.1k

Countries citing papers authored by Michael Halberthal

Since Specialization
Citations

This map shows the geographic impact of Michael Halberthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Halberthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Halberthal more than expected).

Fields of papers citing papers by Michael Halberthal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Halberthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Halberthal. The network helps show where Michael Halberthal may publish in the future.

Co-authorship network of co-authors of Michael Halberthal

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Halberthal. A scholar is included among the top collaborators of Michael Halberthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Halberthal. Michael Halberthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angel, Yoel, et al.. (2025). Trends in Israel's Medical Administration subspecialty, 1987–2022. Israel Journal of Health Policy Research. 14(1). 3–3.
2.
Cohen, S. Robin, Liat Etshtein, Amir Hadash, et al.. (2024). Burden of viral respiratory infections in the pediatric intensive care unit: age, virus distribution, and the impact of the COVID-19 pandemic. European Journal of Pediatrics. 184(1). 88–88. 3 indexed citations
3.
Shachor‐Meyouhas, Yael, Ronit Leiba, Moran Szwarcwort‐Cohen, et al.. (2023). Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers. Vaccines. 11(2). 283–283. 3 indexed citations
4.
Braun, Eyal, Netanel A. Horowitz, Ronit Leiba, et al.. (2022). Association between IgG antibody levels and adverse events after first and second Bnt162b2 mRNA vaccine doses. Clinical Microbiology and Infection. 28(12). 1644–1648. 6 indexed citations
5.
Borenstein‐Levin, Liron, Ori Hochwald, Josef Ben‐Ari, et al.. (2022). Same baby, different care: variations in practice between neonatologists and pediatric intensivists. European Journal of Pediatrics. 181(4). 1669–1677. 13 indexed citations
6.
Pollack, Shirley, Amir Hadash, Danny Eytan, et al.. (2022). Acute hemodialysis therapy in neonates with inborn errors of metabolism. Pediatric Nephrology. 37(11). 2725–2732. 5 indexed citations
7.
Goshen‐Lago, Tal, Moran Szwarcwort‐Cohen, Anat Reiner‐Benaim, et al.. (2021). Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors. Cancer Discovery. 11(10). 2430–2435. 37 indexed citations
8.
Shachor‐Meyouhas, Yael, Khetam Hussein, Moran Szwarcwort‐Cohen, et al.. (2021). Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel. Clinical Microbiology and Infection. 28(3). 450.e1–450.e4. 7 indexed citations
9.
Ben‐Aharon, Irit, et al.. (2021). 1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients. Annals of Oncology. 32. S1130–S1130. 2 indexed citations
10.
Bahouth, Hany, et al.. (2021). Preparedness for Mass Casualty Incidents: The Effectiveness of Current Training Model. Disaster Medicine and Public Health Preparedness. 16(5). 2120–2128. 8 indexed citations
11.
Berger, Gidon, Netanel A. Horowitz, Yael Shachor‐Meyouhas, et al.. (2021). Hospital solution for COVID-19 isolation facility. American Journal of Disaster Medicine. 16(1). 35–41. 2 indexed citations
12.
Berger, Gidon, et al.. (2021). Career Trajectory of Physicians Following a Fellowship Program: A Descriptive Study. Rambam Maimonides Medical Journal. 12(2). e0011–e0011. 2 indexed citations
13.
Yelin, Idan, Einat Shaer Tamar, Amir Argoetti, et al.. (2020). Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools. Clinical Infectious Diseases. 71(16). 2073–2078. 248 indexed citations
14.
Berger, Gidon, et al.. (2020). Delayed discharges from a tertiary teaching hospital in Israel- incidence, implications, and solutions. Israel Journal of Health Policy Research. 9(1). 66–66. 1 indexed citations
15.
Halberthal, Michael, Dean Nachman, Arik Eisenkraft, & Eli Jaffe. (2020). Hospital and home remote patient monitoring during the COVID-19 outbreak: A novel concept implemented. American Journal of Disaster Medicine. 15(2). 149–151. 6 indexed citations
16.
Bar-El, Yaron, et al.. (2013). Decision-Support Information System to Manage Mass Casualty Incidents at a Level 1 Trauma Center. Disaster Medicine and Public Health Preparedness. 7(6). 549–554. 8 indexed citations
17.
Bar‐Joseph, Gad, Moshe Michaelson, & Michael Halberthal. (2003). Managing mass casualties. Current Opinion in Anaesthesiology. 16(2). 193–199. 4 indexed citations
18.
Epelman, Mónica, et al.. (2002). Abdominal compartment syndrome in children: CT findings. Pediatric Radiology. 32(5). 319–322. 23 indexed citations
19.
20.
Makhoul, Imad R., et al.. (1998). Intratracheal Pulmonary Ventilation in Premature Infants and Children With Intractable Hypercapnia. ASAIO Journal. 44(1). 82–88. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026